Document is current

Any future updates will be listed below

Correction: Severe immune-related adverse event colitis successfully treated with single-dose infliximab in an older adult with hepatocellular carcinoma receiving STRIDE therapy

Crossref DOI link: https://doi.org/10.1007/s12328-025-02212-0

Published Online: 2025-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark